Literature DB >> 23303713

Proteomic methods reveal cyclophilin A function as a host restriction factor against rotavirus infection.

Haiyang He1, Zhirong Mou, Wanling Li, Lei Fei, Yan Tang, Ji Zhang, Ping Yan, Zhengqiong Chen, Xia Yang, Zigang Shen, Jintao Li, Yuzhang Wu.   

Abstract

Rotavirus (RV) infection is the main cause of acute dehydrating diarrhea in infants and young children below 5 years old worldwide. RV infection causes a global shutoff of host proteins as many other viruses do. However, previous studies revealed that RV could selectively upregulated the expression of some host proteins that then played important roles in RV infection. To globally explor such host proteins that were upregulated in early human rotavirus (HRV) infection, proteomic methods were used and a total of ten upregulated host proteins were unambiguously identified. Cyclophilin A (CYPA), a peptidyl-prolyl cis-trans isomerase, was among these upregulated host proteins. Following infection, CYPA was recruited to the viroplasm and interacted with HRV structural protein VP2; CYPA reduced host susceptibility to HRV infection and inhibited replication of HRV by repressing the expression of viral proteins. Furthermore, we found that the increased expression of CYPA in enterocytes of small intestine correlated to the period when BALB/c mice became resistant to RV diarrhea. Together, we identified CYPA as a novel host restriction factor that confered protection against RV infection and might contribute to host susceptibility to RV diarrhea.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303713     DOI: 10.1002/pmic.201100579

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  8 in total

Review 1.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

Review 2.  Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents.

Authors:  Jinhe Han; Myoung Kyu Lee; Yejin Jang; Won-Jea Cho; Meeheyin Kim
Journal:  Drug Discov Today       Date:  2022-05-21       Impact factor: 8.369

3.  Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.

Authors:  Wenzhang Liang; Yue Zhang; Miao Li; Fadhl Al-Shaebi; Jian Li; Jing Zhang; Lin Wei
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

4.  Cyclosporin a inhibits rotavirus replication and restores interferon-beta signaling pathway in vitro and in vivo.

Authors:  Zigang Shen; Haiyang He; Yuzhang Wu; Jintao Li
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

5.  Inhibition of Cyclophilin A on the replication of red spotted grouper nervous necrosis virus associates with multiple pro-inflammatory factors.

Authors:  Muhammad Asim; V Sarath Babu; Zhendong Qin; Lijuan Zhao; Jianguo Su; Jun Li; Jiagang Tu; Hongyan Kou; Li Lin
Journal:  Fish Shellfish Immunol       Date:  2019-06-05       Impact factor: 4.581

Review 6.  Cyclophilin A: a key player for etiological agent infection.

Authors:  Yating Liao; Dan Luo; Kailan Peng; Yanhua Zeng
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-25       Impact factor: 5.560

7.  Acute Heat Stress and Reduced Nutrient Intake Alter Intestinal Proteomic Profile and Gene Expression in Pigs.

Authors:  Sarah C Pearce; Steven M Lonergan; Elisabeth Huff-Lonergan; Lance H Baumgard; Nicholas K Gabler
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

8.  A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers.

Authors:  Federica Ciregia; Laura Giusti; Ylenia Da Valle; Elena Donadio; Arianna Consensi; Camillo Giacomelli; Francesca Sernissi; Pietro Scarpellini; Fabrizio Maggi; Antonio Lucacchini; Laura Bazzichi
Journal:  J Transl Med       Date:  2013-10-02       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.